High GPER expression in triple-negative breast cancer is linked to pro-metastatic pathways and predicts poor patient outcomes

Triple-negative breast cancer (TNBC) is a particularly aggressive and heterogeneous disease with few effective targeted therapies and precision therapeutic options over a long period. It is generally considered that TNBC is an estrogen-independent breast cancer, while a new estrogen receptor, namely...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Ting, Ma, Ding, Chen, Sheng, Tang, Rui, Yang, Jianling, Meng, Chunhui, Feng, Yang, Liu, Li, Wang, Jiangfen, Luo, Haojun, Yu, Keda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427744/
https://www.ncbi.nlm.nih.gov/pubmed/36042244
http://dx.doi.org/10.1038/s41523-022-00472-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427744/
https://www.ncbi.nlm.nih.gov/pubmed/36042244
http://dx.doi.org/10.1038/s41523-022-00472-4

Ejemplares similares